Cabozantinib S-malate
| CAS No. | 1140909-48-3 |
|---|---|
| MDL No. | MFCD20923480 |
| MF | C32H30FN3O10 |
| MW | 635.60 |
| InChI Key | HFCFMRYTXDINDK-WNQIDUERSA-N |
| CAS No. | 1140909-48-3 |
|---|---|
| MDL No. | MFCD20923480 |
| MF | C32H30FN3O10 |
| MW | 635.60 |
| InChI Key | HFCFMRYTXDINDK-WNQIDUERSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Cabozantinib malate is the mono-(S)-malate salt of cabozantinib, a multi-tyrosine kinase inhibitor used to treat progressive, metastatic medullary thyroid cancer. It functions as a tyrosine kinase inhibitor, antineoplastic agent, and prodrug.
| CAS No. | 1140909-48-3 |
|---|---|
| Product Name | Cabozantinib S-malate |